New Jersey’s Life Science Cluster Anchor to the Medicine Chest of the World
Hillside, NJ, August 5, 2004 — The pharmaceutical and medical technology industry has long been an economic engine in New Jersey, with many companies arriving here more than a century ago. Now, a groundbreaking study conducted by renowned Harvard Professor Michael E. Porter underscores the importance of this industry to the state’s “life sciences cluster.”
BD Chairman Edward J. Ludwig to Lead HealthCare Institute of New Jersey
Hillside, NJ, July 19, 2004 — Edward J. Ludwig, Chairman, President and Chief Executive Officer of BD (Becton, Dickinson and Company) (NYSE:BDX), has recently been elected Chairman of the HealthCare Institute of New Jersey (HINJ). Mr. Ludwig will serve a two-year term and is the first executive from a medical technology company to lead the […]
HINJ Releases 2004 Economic Impact Report: Impact of HINJ Members Climbs to $23.8 Billion
NJ’s Pharmaceutical & Medical Technology Industry Continues to Drive State’s Economy Industry created 156,000 jobs – 63,000 direct + 93, 000 spin-off jobs Average base salary is $85, 423 Payroll Impacts of $6 billion Charitable Contributions totaled $155 million $213.1 M in sales tax and income tax impacts on NJ Hillside, NJ, April 27, 2004 […]
The State of Our Life Sciences Industry
By The Honorable Bob Franks, President, HealthCare Institute of New Jersey Hillside, NJ, February 2, 2004 —Nowhere on earth is there a more important place for the pharmaceutical and medical technology industry than our own state of New Jersey.